全文获取类型
收费全文 | 159785篇 |
免费 | 32879篇 |
国内免费 | 2442篇 |
专业分类
耳鼻咽喉 | 5249篇 |
儿科学 | 5608篇 |
妇产科学 | 2575篇 |
基础医学 | 4284篇 |
口腔科学 | 1708篇 |
临床医学 | 27179篇 |
内科学 | 49742篇 |
皮肤病学 | 7585篇 |
神经病学 | 16074篇 |
特种医学 | 6569篇 |
外科学 | 42693篇 |
综合类 | 274篇 |
现状与发展 | 72篇 |
预防医学 | 7210篇 |
眼科学 | 3686篇 |
药学 | 1631篇 |
中国医学 | 34篇 |
肿瘤学 | 12933篇 |
出版年
2024年 | 516篇 |
2023年 | 4827篇 |
2022年 | 1258篇 |
2021年 | 3229篇 |
2020年 | 6122篇 |
2019年 | 2322篇 |
2018年 | 7567篇 |
2017年 | 7454篇 |
2016年 | 8558篇 |
2015年 | 8550篇 |
2014年 | 15684篇 |
2013年 | 15842篇 |
2012年 | 5840篇 |
2011年 | 5888篇 |
2010年 | 10579篇 |
2009年 | 14425篇 |
2008年 | 6208篇 |
2007年 | 4415篇 |
2006年 | 6953篇 |
2005年 | 4306篇 |
2004年 | 3545篇 |
2003年 | 2532篇 |
2002年 | 2586篇 |
2001年 | 4120篇 |
2000年 | 3350篇 |
1999年 | 3503篇 |
1998年 | 3807篇 |
1997年 | 3588篇 |
1996年 | 3472篇 |
1995年 | 3307篇 |
1994年 | 2040篇 |
1993年 | 1649篇 |
1992年 | 1639篇 |
1991年 | 1652篇 |
1990年 | 1299篇 |
1989年 | 1410篇 |
1988年 | 1219篇 |
1987年 | 1025篇 |
1986年 | 1046篇 |
1985年 | 874篇 |
1984年 | 684篇 |
1983年 | 640篇 |
1982年 | 576篇 |
1981年 | 446篇 |
1980年 | 407篇 |
1979年 | 408篇 |
1978年 | 386篇 |
1977年 | 465篇 |
1975年 | 330篇 |
1972年 | 373篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
81.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献
82.
83.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
84.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
85.
86.
87.
88.
Tetsuo Shoji Yoshiki Nishizawa 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2006,10(Z1):S27-S33
Abstract: The risk of cardiovascular death is high in hemodialysis (HD) patients, and thickening, stiffening and calcification of the arterial wall have been shown as its predictive factors. Activated vitamin D preparations are used for the treatment of secondary hyperparathyroidism in HD patients, but as they increase serum phosphate and calcium concentrations, there is a concern that they promote vascular calcification and, consequently, exacerbate the outcomes. In this article, the effects of vitamin D therapy on survival, cardiac function, arteriosclerosis, immunity, and inflammation are evaluated by reviewing the literature. In HD patients, the risk of death (particularly cardiovascular death) is significantly lower in those treated than in those not treated with vitamin D. Moreover, activated vitamin D improves cardiac function and alleviates cardiac hypertrophy in HD patients. Experimental data in cultured macrophages, vascular smooth muscle cells, and vascular endothelial cells suggest that it has antiatherosclerotic effects. In vivo, the administration of vitamin D improves immune functions and normalizes inflammatory reactions. In HD patients, vascular calcification is related to the dose of calcium carbonate, but its relationship with the administration of vitamin D is not significant. These observations suggest that, contrary to the general concerns, activated vitamin D exerts favorable effects on the cardiovascular system in HD patients as long as it is used in appropriate clinical doses. 相似文献
89.
Juliette A. Loncaster MD FRCR Ernest Allan 《Photodiagnosis and Photodynamic Therapy》2006,3(2):134-137
Gorlin syndrome (naevoid basal cell carcinoma syndrome) is a genetically linked disorder characterized by the development of multiple basal cell carcinomas (BCCs) throughout life. Cumulative surgery, cryotherapy and other conventional interventions can result in significant disfigurement by middle age. Radiotherapy is contra-indicated because the mutated gene underlying the syndrome, ‘PTCH’, increases sensitivity to ionising radiation, so there is significant likelihood of inducing further tumours in and around the irradiated area. Photodynamic therapy offers a non-invasive treatment option for patients with this condition, with the added advantage of causing minimal scarring. 相似文献
90.